Open Design Tools for Speech Signal Processing (R43/R44)
The summary for the Open Design Tools for Speech Signal Processing (R43/R44) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Open Design Tools for Speech Signal Processing (R43/R44): This Funding Opportunity Announcement (FOA) solicits SBIR grant applications to develop and support the use of portable acoustic signal processing tools that provide substantial amounts of computing power and reconfigurable real-time speech enhancement software that operates in real world environments.
This research tool must incorporate open source design principles for key hardware and software components to support rapid dissemination, reconfiguration, and enhancement of tools that enable acoustic psychophysical research studies beyond those widely performed today.
This research tool must incorporate open source design principles for key hardware and software components to support rapid dissemination, reconfiguration, and enhancement of tools that enable acoustic psychophysical research studies beyond those widely performed today.
Federal Grant Title: | Open Design Tools for Speech Signal Processing (R43/R44) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-DC-16-002 |
Type of Funding: | Grant |
CFDA Numbers: | 93.173 |
CFDA Descriptions: | Research Related to Deafness and Communication Disorders |
Current Application Deadline: | Oct 1, 2015 |
Original Application Deadline: | Oct 1, 2015 |
Posted Date: | Jun 8, 2015 |
Creation Date: | Jun 8, 2015 |
Archive Date: | Nov 1, 2015 |
Total Program Funding: | $1,000,000 |
Maximum Federal Grant Award: | $1,000,000 |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses
- Additional Information on Eligibility
- Other Eligible Applicants include the following:
Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity. See announcement for full details. - Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-DC-16-002.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405 - Similar Government Grants
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • Medical Rehabilitation Research Resource (P50 Clinical Trial Optional)
- • Optimizing Health of Children and Adolescents with Perinatal HIV Exposure (U19 Clinical Tr...
- • BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Centr...
- • NIDCD Patient-Oriented Research Grant (R21)
- • Cell Lineage and Developmental Studies in Hearing and Balance
- • Structural Analyses of the Ligand-Binding Properties of Taste and Smell Receptors
- More Grants from the National Institutes of Health
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...
- • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...
- • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
- • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...